These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 24198417)

  • 1. Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor.
    Ortiz-Riaño E; Ngo N; Devito S; Eggink D; Munger J; Shaw ML; de la Torre JC; Martínez-Sobrido L
    J Virol; 2014 Jan; 88(2):878-89. PubMed ID: 24198417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity.
    Miranda PO; Cubitt B; Jacob NT; Janda KD; de la Torre JC
    ACS Infect Dis; 2018 May; 4(5):815-824. PubMed ID: 29405696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arenavirus Quasispecies and Their Biological Implications.
    Grande-Pérez A; Martin V; Moreno H; de la Torre JC
    Curr Top Microbiol Immunol; 2016; 392():231-76. PubMed ID: 26472215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
    Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication.
    Ngo N; Henthorn KS; Cisneros MI; Cubitt B; Iwasaki M; de la Torre JC; Lama J
    J Virol; 2015 Nov; 89(21):10924-33. PubMed ID: 26292327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors.
    Neuman BW; Bederka LH; Stein DA; Ting JP; Moulton HM; Buchmeier MJ
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4631-8. PubMed ID: 21825302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverse genetics approaches to combat pathogenic arenaviruses.
    de la Torre JC
    Antiviral Res; 2008 Dec; 80(3):239-50. PubMed ID: 18782590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arenavirus reverse genetics for vaccine development.
    Ortiz-Riaño E; Cheng BYH; Carlos de la Torre J; Martínez-Sobrido L
    J Gen Virol; 2013 Jun; 94(Pt 6):1175-1188. PubMed ID: 23364194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-705 (favipiravir) inhibition of arenavirus replication in cell culture.
    Mendenhall M; Russell A; Juelich T; Messina EL; Smee DF; Freiberg AN; Holbrook MR; Furuta Y; de la Torre JC; Nunberg JH; Gowen BB
    Antimicrob Agents Chemother; 2011 Feb; 55(2):782-7. PubMed ID: 21115797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribavirin can be mutagenic for arenaviruses.
    Moreno H; Gallego I; Sevilla N; de la Torre JC; Domingo E; Martín V
    J Virol; 2011 Jul; 85(14):7246-55. PubMed ID: 21561907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of non-standard viral genomes during arenavirus infections identifies prominent S RNA intergenic region deletions.
    Hackbart M; López CB
    mBio; 2024 Oct; 15(10):e0161224. PubMed ID: 39258905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arenaviruses and lethal mutagenesis. Prospects for new ribavirin-based interventions.
    Moreno H; Grande-Pérez A; Domingo E; Martín V
    Viruses; 2012 Nov; 4(11):2786-805. PubMed ID: 23202505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Arenavirus Entry Inhibitors Discovered by Using a Minigenome Rescue System for High-Throughput Drug Screening.
    Rathbun JY; Droniou ME; Damoiseaux R; Haworth KG; Henley JE; Exline CM; Choe H; Cannon PM
    J Virol; 2015 Aug; 89(16):8428-43. PubMed ID: 26041296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitors.
    Kim YJ; Cubitt B; Chen E; Hull MV; Chatterjee AK; Cai Y; Kuhn JH; de la Torre JC
    Antiviral Res; 2019 Sep; 169():104558. PubMed ID: 31302150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arenavirus extinction through lethal mutagenesis.
    de la Torre JC
    Virus Res; 2005 Feb; 107(2):207-14. PubMed ID: 15649566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of live-attenuated arenavirus vaccines based on codon deoptimization.
    Cheng BY; Ortiz-Riaño E; Nogales A; de la Torre JC; Martínez-Sobrido L
    J Virol; 2015 Apr; 89(7):3523-33. PubMed ID: 25589652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.
    Cheng BY; Ortiz-Riaño E; de la Torre JC; Martínez-Sobrido L
    J Virol; 2015 Jul; 89(14):7373-84. PubMed ID: 25972555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening and Identification of Lujo Virus Inhibitors Using a Recombinant Reporter Virus Platform.
    Welch SR; Spengler JR; Genzer SC; Chatterjee P; Flint M; Bergeron É; Montgomery JM; Nichol ST; Albariño CG; Spiropoulou CF
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34203149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arenavirus research and antiviral candidate].
    Tani H; Shuzo U
    Uirusu; 2018; 68(1):51-62. PubMed ID: 31105135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses.
    de la Torre JC
    Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E57-64. PubMed ID: 19751403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.